- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
DND PharmaTech Inc (347850)
DND PharmaTech Inc stock price live, this page displays KQ 347850 stock exchange data. View the 347850 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the DND PharmaTech Inc real time stock price chart below.
What Is the DND PharmaTech Inc Stock Price Today?
The DND PharmaTech Inc stock price today is 97,700.00.
What Is the Stock Symbol for DND PharmaTech Inc?
The stock symbol for DND PharmaTech Inc is "347850."
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 347850 quote. (ISIN: KR7347850000)
What Is the DND PharmaTech Inc Stock Price Today?
The DND PharmaTech Inc stock price today is 97,700.00.
What Is the Stock Symbol for DND PharmaTech Inc?
The stock symbol for DND PharmaTech Inc is "347850."
What Stock Exchange Does DND PharmaTech Inc Trade On?
DND PharmaTech Inc is listed and trades on the KOSDAQ stock exchange.
Is DND PharmaTech Inc a Good Stock to Buy?
Determining whether DND PharmaTech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 347850 quote. (ISIN: KR7347850000)
KOSDAQ
Currency in KRW
97,700.00
+2,800.00(+2.95%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94,100.00
98,900.00
52 wk Range
10,125.00
200,500.00
347850 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94,100.0098,900.00
52 wk Range
10,125.00200,500.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
347850 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Biotechnology industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
DND PharmaTech Inc Company Profile
D&D Pharmatech Inc., a clinical-stage biotech company, develops medicines in South Korea and the United States. It develops NLY01-PD, NLY01-AD, and NLY01-D that are in Phase II clinical trials for the treatment of Parkinson’s disease (PD), Alzheimer’s disease (AD), and type 2 diabetes; and P4M01, which has completed Phase IIa clinical trials to treat periodontal disease. The company also develops DD01 that is in Phase I clinical trials for the treatment of obesity/diabetes/nonalcoholic steatohepatitis (NASH); TLY012, which is Phase I clinical trials to treat NASH-liver fibrosis, chronic pancreatitis, and systemic sclerosis; PMI03 that is in Phase I clinical trials for the treatment of PD, AD, and neuroinflammation; PMI04, which is in Phase I clinical trials to treat PD, AD, ALS, and depression; and PMI05 and PMI06 that are in Phase I clinical trials for the treatment of oncology and immuno-oncology. Its preclinical drug candidates include NLY03 for stroke/PD; DD03 to treat obesity and NASH; TLY014 for the treatment of tumor microenvironment; PMI31 for various cancers; and VT01 to treat PD. In addition, the company develops NLY02 for the treatment of PD & AD; NLY12 for type 2 diabetes and obesity; DD02 to treat type 2 diabetes; PMI21 for the treatment of prostate cancer; and PMI07 for oncology and fibrosis. Further, it focuses on the application of big data in CNS drug research and diagnostics. The company was founded in 2014 and is based in Seongnam-si, South Korea.
Compare 347850 to Peers and Sector
Metrics to compare | 347850 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship347850PeersSector | |
|---|---|---|---|---|
P/E Ratio | −118.6x | −13.3x | −0.6x | |
PEG Ratio | −4.92 | −0.11 | 0.00 | |
Price/Book | 54.7x | 3.4x | 2.6x | |
Price / LTM Sales | 492.8x | 23.6x | 3.2x | |
Upside (Analyst Target) | - | 14.3% | 42.3% | |
Fair Value Upside | Unlock | −8.3% | 5.9% | Unlock |
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
-521.00 / --
Revenue / Forecast
969.49M / --
People Also Watch
FAQ
What Is the DND PharmaTech (347850) Stock Price Today?
The DND PharmaTech stock price today is 97,700.00
What Stock Exchange Does DND PharmaTech Trade On?
DND PharmaTech is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for DND PharmaTech?
The stock symbol for DND PharmaTech is "347850."
What Is the DND PharmaTech Market Cap?
As of today, DND PharmaTech market cap is 4.12T.
What Is DND PharmaTech's Earnings Per Share (TTM)?
The DND PharmaTech EPS (TTM) is -845.57.
From a Technical Analysis Perspective, Is 347850 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has DND PharmaTech Stock Split?
DND PharmaTech has split 1 times.
What is the current trading status of DND PharmaTech (347850)?
As of Dec 29, 2025, DND PharmaTech (347850) is trading at a price of 97,700.00, with a previous close of 94,900.00. The stock has fluctuated within a day range of 94,100.00 to 98,900.00, while its 52-week range spans from 10,125.00 to 200,500.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.